Dr. Scott Michael Letellier, MD

Dr. Letellier practices at PeaceHealth St. Joseph Medical Center in Bellingham, Washington, part of PeaceHealth.

Dr. Letellier's NPI, 1063703809, was assigned on April 27, 2011. Dr. Letellier holds Washington license MD60459476.

Dr. Letellier's primary practice is PeaceHealth St. Joseph Medical Center, at 2901 Squalicum Parkway, Bellingham, WA 98225 in Whatcom County. The practice phone is (360) 734-5400.

Dr. Letellier's primary practice is PeaceHealth St. Joseph Medical Center in Bellingham, Washington, part of PeaceHealth. Dr. Letellier is also affiliated with Island Health. The medical group on file is PeaceHealth Medical Group. Dmand AI also links Dr. Letellier to 4 more hospitals, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Letellier practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Letellier's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Letellier is licensed in Washington.

CMS data shows 2,278 Medicare services from Dr. Letellier across 9 procedure codes in 2024, for 478 Medicare patients. Medicare paid $139,268 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 478 Medicare patients who saw Dr. Letellier in 2024. The largest group is 75 to 84, with 211 patients. 66% of them have high blood pressure, and 64% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Letellier's median patient age at 75, with 53% women.

In 2024, Dr. Letellier wrote 4,733 Medicare Part D claims for 610 patients. 80% of them were for generic drugs. CMS names the drug for 4,294 of them, across 85 drugs with 11 or more claims each, at $10,323,416 in total drug cost. In 2023, CMS named 3,772 claims across 74 drugs.

Dr. Letellier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Letellier as offering telehealth.

Dmand AI links Dr. Letellier to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 166 general payments to Dr. Letellier from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Celgene Corporation paid the most, $292.